Single-Dose Phase 1 Study of TAK-792 (Q64376509)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Single-Dose Phase 1 Study of TAK-792 |
clinical trial |
Statements
A Randomized, Single-Center, Double-Blind, Placebo-Controlled, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Oral Dose of TAK-792 in Healthy Subjects (English)
0 references
27 May 2015
0 references
28 January 2016
0 references
72
0 references
20 year
0 references
45 year
0 references